about
Effect of diets containing sucrose vs. D-tagatose in hypercholesterolemic mice.Effects of Three Low-Doses of D-Tagatose on Glycemic Control Over Six Months in Subjects with Mild Type 2 Diabetes Mellitus Under Control with Diet and Exercise.The Effect of D-Tagatose on Fructose Absorption in a Rat ModelThe acid-tolerant L-arabinose isomerase from the mesophilic Shewanella sp. ANA-3 is highly active at low temperaturesSn-Beta zeolites with borate salts catalyse the epimerization of carbohydrates via an intramolecular carbon shift.The secreted L-arabinose isomerase displays anti-hyperglycemic effects in miceA method for the production of D-tagatose using a recombinant Pichia pastoris strain secreting β-D-galactosidase from Arthrobacter chlorophenolicus and a recombinant L-arabinose isomerase from Arthrobacter sp. 22c.Safety and Efficacy of D-Tagatose in Glycemic Control in Subjects with Type 2 Diabetes.BSN723T Prevents Atherosclerosis and Weight Gain in ApoE Knockout Mice Fed a Western Diet.TM0416, a Hyperthermophilic Promiscuous Nonphosphorylated Sugar Isomerase, Catalyzes Various C5 and C6 Epimerization ReactionsTwo-step enzymatic synthesis of 6-deoxy-L-psicose.Biochemical analysis and the preliminary crystallographic characterization of D-tagatose 3-epimerase from Rhodobacter sphaeroides.D-Tagatose Is a Promising Sweetener to Control Glycaemia: A New Functional Food.Biochemical properties of L-arabinose isomerase from Clostridium hylemonae to produce D-tagatose as a functional sweetener.The Ability of Different Ketohexoses to Alter Apo-A-I Structure and Function In Vitro and to Induce Hepatosteatosis, Oxidative Stress, and Impaired Plasma Lipid Profile in Hyperlipidemic Zebrafish.
P2860
Q33835927-A8B95EEF-27BF-4B15-83D4-17E966E16E38Q34457696-35A99C98-0D9D-4D33-B4E0-247431A0DBBEQ34993272-3A4FA74C-FF1F-4368-B9EE-3501119F441BQ35642741-F5786DB9-C484-4B95-BF9A-75EC10B252D2Q36384862-24DF3505-615E-4DE1-87AE-DC9EF7F949AAQ36393273-C6396F81-F4AC-4DA4-81F3-B3310532D8CCQ36462623-342CDF72-CA3F-4E14-A1F2-EB09A8D46F0DQ36763213-64E8A690-BDD2-4BBA-8EF2-9BC7ACEBBAAFQ37284232-A9430235-A579-41A7-855B-8069ED0014F7Q38930561-9C265C93-B226-4C4D-8C4E-839EE7853A9AQ41665672-074CF7E0-1846-47E7-A285-14E91D8F391BQ47111217-375AE9C9-F33E-47CB-BE0A-E9F827D45EC1Q52652931-AE86CBD8-60F2-4CE7-B904-D3E9B7F790FAQ55101108-CA23EF50-C35C-443A-B8FC-B56025216F91Q55434032-DA8441C8-2C32-4202-A562-5AF1E2730C1F
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tagatose, a new antidiabetic and obesity control drug.
@en
type
label
Tagatose, a new antidiabetic and obesity control drug.
@en
prefLabel
Tagatose, a new antidiabetic and obesity control drug.
@en
P2093
P2860
P1476
Tagatose, a new antidiabetic and obesity control drug.
@en
P2093
P2860
P304
P356
10.1111/J.1463-1326.2007.00799.X
P577
2007-10-15T00:00:00Z